Genmab | GEN - EPS - Lucro por Ação

Preço das Ações
1,839.00
Mudança Diária
-4.00 -0.22%
Mensal
7.26%
Anual
42.39%
Q2 Previsão
1,699.78

Fiscal Calendário Atual Consenso Anterior Data
FY2025Q2 Jun/2025 34.31 26.44 21.70 Aug/07
FY2025Q1 Mar/2025 20.19 16.27 20.18 May/08
FY2024Q4 Dec/2024 59.49 24.90 9.66 Feb/12
FY2024Q3 Sep/2024 19.94 21.70 32.46 Nov/06
FY2024Q2 Jun/2024 21.70 21.35 20.61 Aug/08




Eps Alterar Data
Agios Pharmaceuticals USD -1.86 0.08 2025-12
Almirall EUR 0.07 0.03 2025-12
Amarin USD 0.14 0.06 2025-12
Amgen USD 5.29 0.35 2025-12
argenx SE USD 6.8 2.36 2025-12
AstraZeneca USD 2.12 0.26 2025-12
Bayer EUR 0.62 0.05 2025-12
BioMarin Pharmaceutical USD 0.46 0.34 2025-12
Demant DKK 6.1 0.5 2025-12
Exelixis USD 0.97 0.19 2025-12
Fresenius Medical Care EUR 1.44 0.34 2025-12
Galapagos EUR 11.89 12.3 2025-12
Genmab DKK 3.69 2.77 2025-12
GlaxoSmithKline GBP 0.26 0.29 2025-12
GN Store Nord DKK 2.51 2.01 2025-12
GRIFOLS EUR 0.25 0.04 2025-12
Hikma Pharmaceutical USD 0.65 0.12 2025-12
Insmed USD -1.54 0.21 2025-12
Lonza CHF 6.07 1.92 2025-06
Merck EUR 1.88 0.44 2025-12
Novartis USD 1.54 0.5 2025-12
Regeneron Pharmaceuticals USD 11.44 0.39 2025-12
Roche Holding CHF 8.37 2.95 2025-12
Sanofi EUR 1.53 1.38 2025-12
UCB EUR 5.65 3.21 2025-12